0001209191-18-047297.txt : 20180817 0001209191-18-047297.hdr.sgml : 20180817 20180817151638 ACCESSION NUMBER: 0001209191-18-047297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180815 FILED AS OF DATE: 20180817 DATE AS OF CHANGE: 20180817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEAVER JOHN R CENTRAL INDEX KEY: 0001215999 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36385 FILM NUMBER: 181025649 MAIL ADDRESS: STREET 1: C/O STERLING CHEMICALS INC STREET 2: 1200 SMITH STREET CITY: HOUSTON STATE: TX ZIP: 77002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE, INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-15 0 0000811240 BIOLASE, INC BIOL 0001215999 BEAVER JOHN R 4 CROMWELL IRVINE CA 92618 0 1 0 0 EVP & Chief Financial Officer Common Stock 2018-08-15 4 P 0 6077 1.58 A 6077 D Common Stock 2018-08-16 4 P 0 18923 1.70 A 25000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.60, inclusive. The reporting person undertakes to provide to Biolase, Inc., any security holder of Biolase, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.60 to $1.75, inclusive. The reporting person undertakes to provide to Biolase, Inc., any security holder of Biolase, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4. /s/ Michael C. Carroll, attorney-in-fact for John Beaver 2018-08-17